AHCYL Antibodies

Santa Cruz Biotechnology provides a broad selection of AHCYL monoclonal antibodies for research focused on AHCY (S-adenosylhomocysteine hydrolase) in biological processes. AHCYL monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AHCY is a key enzyme in the methionine cycle, catalyzing the hydrolysis of S-adenosylhomocysteine to adenosine and homocysteine. The hydrolysis process plays a vital role in maintaining cellular methylation reactions and regulating levels of key metabolites. Research has shown that AHCY dysfunction can lead to various pathological conditions. Understanding AHCY's molecular mechanisms and cellular functions continues to be an active area of investigation. Ongoing studies focus on identifying potential therapeutic approaches targeting AHCY-related pathways. AHCYL monoclonal antibodies enable precise detection and analysis of AHCY expression patterns and interactions. Santa Cruz Biotechnology's AHCYL monoclonal antibodies support researchers worldwide in advancing our understanding of cellular metabolism and disease mechanisms.